334 related articles for article (PubMed ID: 24623647)
21. Fabrication of cRGD-modified reduction-sensitive nanocapsule via Pickering emulsion route to facilitate tumor-targeted delivery.
Shang X; Liu Q; Qin T; Xu X; Sun H; Liu M; Zhu H
Int J Nanomedicine; 2019; 14():3361-3373. PubMed ID: 31190797
[No Abstract] [Full Text] [Related]
22. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
[TBL] [Abstract][Full Text] [Related]
23. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
24. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
25. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
26. Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core-shell nanoparticles targeting the heterogeneous tumor cells of glioma.
Xu HL; Fan ZL; ZhuGe DL; Tong MQ; Shen BX; Lin MT; Zhu QY; Jin BH; Sohawon Y; Yao Q; Zhao YZ
Drug Deliv; 2018 Nov; 25(1):1302-1318. PubMed ID: 29869524
[TBL] [Abstract][Full Text] [Related]
27. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
28. pH sensitive surfactant-stabilized Fe
Dutta B; Shetake NG; Barick BK; Barick KC; Pandey BN; Priyadarsini KI; Hassan PA
Colloids Surf B Biointerfaces; 2018 Feb; 162():163-171. PubMed ID: 29190467
[TBL] [Abstract][Full Text] [Related]
29. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.
Pang Z; Feng L; Hua R; Chen J; Gao H; Pan S; Jiang X; Zhang P
Mol Pharm; 2010 Dec; 7(6):1995-2005. PubMed ID: 20957995
[TBL] [Abstract][Full Text] [Related]
31. Near-Infrared Triggered Decomposition of Nanocapsules with High Tumor Accumulation and Stimuli Responsive Fast Elimination.
Zhao T; Wang P; Li Q; Al-Khalaf AA; Hozzein WN; Zhang F; Li X; Zhao D
Angew Chem Int Ed Engl; 2018 Mar; 57(10):2611-2615. PubMed ID: 29336520
[TBL] [Abstract][Full Text] [Related]
32. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
33. One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin.
Peng J; Fumoto S; Miyamoto H; Chen Y; Kuroda N; Nishida K
J Drug Target; 2017 Sep; 25(8):704-714. PubMed ID: 28368667
[TBL] [Abstract][Full Text] [Related]
34. Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma.
Zhang M; Asghar S; Tian C; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Carbohydr Polym; 2021 Feb; 253():117194. PubMed ID: 33278970
[TBL] [Abstract][Full Text] [Related]
35. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Hemotoxicity of Stealth Doxorubicin-Loaded Magnetic Nanovectors on Breast Cancer Xenografts.
Gautier J; Allard-Vannier E; Burlaud-Gaillard J; Domenech J; Chourpa I
J Biomed Nanotechnol; 2015 Jan; 11(1):177-89. PubMed ID: 26301312
[TBL] [Abstract][Full Text] [Related]
37. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
38. Spindle-like polypyrrole hollow nanocapsules as multifunctional platforms for highly effective chemo-photothermal combination therapy of cancer cells in vivo.
Wang Y; Xiao Y; Tang R
Chemistry; 2014 Sep; 20(37):11826-34. PubMed ID: 25077695
[TBL] [Abstract][Full Text] [Related]
39. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
40. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
